Erik Nestor Newman

Erik Newman practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Erik Newman's NPI, 1649665886, was assigned on April 4, 2015. Erik Newman graduated from University Of Washington School Of Medicine in 2015. Erik Newman holds Utah license 10102300-1205.

Erik Newman's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Erik Newman's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Erik Newman is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Dermatology. Dmand AI also links Erik Newman to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Erik Newman practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Erik Newman's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Erik Newman is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Erik Newman's licenses on file in 2 states: Utah and Colorado.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis and immune deficiency disease among the conditions Erik Newman treats.

CMS data shows 97 Medicare services from Erik Newman across 2 procedure codes in 2024, for 66 Medicare patients. Medicare paid $2,947 for them. Every service was in an office.

CMS counts 66 Medicare patients who saw Erik Newman in 2024. The largest group is 65 to 74, with 39 patients. 58% of them have high blood pressure, and 55% have high cholesterol. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Erik Newman's median patient age at 37, with 55% women.

In 2024, Erik Newman wrote 163 Medicare Part D claims for 44 patients. 50% of them were for generic drugs. CMS names the drug for 88 of them, across 4 drugs with 11 or more claims each, at $11,323 in total drug cost. In 2023, CMS named 64 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Erik Newman for performance year 2024, reported as part of a group. Erik Newman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Erik Newman, published from 2012 to 2021. Erik Newman's most frequent co-authors are Douglas S. Hawkins and Ryan B. Israelsen, MD.

CMS Open Payments shows 4 general payments to Erik Newman from 3 drug and device companies from 2019 to 2022. Grants make up the largest share, 82% of the total. Sanofi and Genzyme US Companies paid the most, $700.

Erik Newman graduated from University Of Washington School Of Medicine in 2015.

Erik Newman is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.